US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist

1.670
-0.050-2.91%

Close Dec 2 16:00 ET

1.670
0.0000.00%

Post 19:51 ET

122.97MMarket Cap-11133P/E (TTM)

Protalix Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

159.60%4.11M

-172.59%-3.61M

239.69%4.19M

94.73%-1.32M

237.69%3.6M

25.16%-6.89M

167.60%4.97M

48.57%-3M

-143.07%-25M

48.67%-2.61M

Net income from continuing operations

274.73%3.24M

-111.39%-2.2M

-46.76%-4.6M

155.68%8.31M

-61.60%-6.04M

48.08%-1.85M

462.56%19.34M

-36.96%-3.13M

45.88%-14.93M

43.90%-3.74M

Operating gains losses

102.78%3K

109.09%1K

-75.00%5K

92.96%-38K

139.35%61K

-325.00%-108K

97.88%-11K

-76.47%20K

-166.42%-540K

-2,037.50%-155K

Depreciation and amortization

7.87%329K

8.87%319K

15.00%322K

9.67%1.19M

13.82%313K

11.72%305K

9.33%293K

3.70%280K

-2.86%1.09M

6.18%275K

Deferred tax

1,065.79%443K

97.80%-69K

---138K

---3.09M

--0

--38K

---3.13M

--0

Other non cash items

483.95%1.15M

-21.74%-504K

-4,181.82%-471K

12.92%-600K

-27.06%124K

-464.15%-299K

39.39%-414K

91.06%-11K

-122.30%-689K

-57.82%170K

Change In working capital

72.42%-1.67M

81.36%-2.15M

1,251.57%8.08M

12.28%-10.54M

2,491.33%7.77M

4.08%-6.07M

-738.20%-11.54M

84.78%-702K

-221.35%-12.02M

-39.02%300K

-Change in receivables

294.50%8.38M

-90.44%-7.05M

-54.33%1.75M

64.15%-428K

-16.41%3.76M

25.33%-4.31M

-254.98%-3.7M

265.21%3.82M

-15.70%-1.19M

47.81%4.5M

-Change in inventory

280.70%3.52M

143.56%1.63M

5.66%-3.3M

-294.87%-2.24M

213.20%2.54M

-200.15%-1.95M

667.82%668K

-357.28%-3.5M

123.60%1.15M

30.46%-2.24M

-Change in payables and accrued expense

-590.96%-869K

-50.97%1.61M

-500.57%-1.41M

210.22%5.3M

503.01%1.48M

-58.45%177K

185.39%3.29M

134.92%353K

-301.43%-4.8M

-127.83%-366K

-Change in other current assets

-177.78%-7K

200.00%6K

55.56%14K

360.00%13K

-96.00%1K

133.33%9K

---6K

--9K

-102.07%-5K

-65.75%25K

-Change in other current liabilities

----

--0

----

--0

----

-Change in other working capital

----

114.05%1.66M

895.32%11.04M

-84.00%-13.18M

--0

-589,600.00%-11.79M

47.54%-1.39M

-154.13%-7.16M

-125.87%-1.62M

Cash from discontinued investing activities

Operating cash flow

159.60%4.11M

-172.59%-3.61M

239.69%4.19M

94.73%-1.32M

237.69%3.6M

25.16%-6.89M

167.60%4.97M

48.57%-3M

-143.07%-25M

48.67%-2.61M

Investing cash flow

Cash flow from continuing investing activities

197.36%20.33M

18.92%-180K

-112.81%-606K

-231.90%-16.71M

-106.90%-342K

-453.16%-20.88M

-162.18%-222K

129.11%4.73M

-126.61%-5.04M

-86.77%4.95M

Net PPE purchase and sale

81.21%-84K

15.69%-172K

-141.13%-598K

-82.96%-1.15M

-17.37%-250K

-670.69%-447K

-59.38%-204K

-8.30%-248K

55.33%-628K

52.46%-213K

Net investment purchase and sale

----

-208.40%-15.42M

--0

-440.33%-20.42M

--0

131.25%5M

-125.00%-5M

-86.78%5M

Net other investing changes

25.00%-9K

55.56%-8K

60.00%-8K

-123.95%-142K

-155.42%-92K

60.00%-12K

-103.71%-18K

28.57%-20K

81.35%593K

238.78%166K

Cash from discontinued investing activities

Investing cash flow

197.36%20.33M

18.92%-180K

-112.81%-606K

-231.90%-16.71M

-106.90%-342K

-453.16%-20.88M

-162.18%-222K

129.11%4.73M

-126.61%-5.04M

-86.77%4.95M

Financing cash flow

Cash flow from continuing financing activities

-20.42M

199.42%24.67M

10.43M

14.23M

-31.79%8.24M

200.72%4.08M

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

--0

190.85%23.95M

--0

--9.72M

--14.23M

-82.17%8.24M

--4.08M

Proceeds from stock option exercised by employees

--0

----

35,500.00%712K

--0

----

--2K

--0

Cash from discontinued financing activities

Financing cash flow

---20.42M

--0

199.42%24.67M

--0

294.74%10.43M

--14.23M

-31.79%8.24M

200.72%4.08M

Net cash flow

Beginning cash position

-51.44%23.4M

-17.64%27.21M

38.12%23.63M

-56.11%17.11M

90.37%20.41M

285.72%48.18M

95.62%33.04M

-56.11%17.11M

113.44%38.99M

0.73%10.72M

Current changes in cash

114.45%4.01M

-124.96%-3.79M

-77.57%3.58M

130.45%6.64M

-49.31%3.25M

-1,466.99%-27.77M

448.58%15.18M

172.29%15.97M

-205.23%-21.8M

-77.33%6.42M

Effect of exchange rate changes

77.78%-2K

44.44%-20K

83.33%-7K

-48.05%-114K

-3.85%-27K

---9K

10.00%-36K

-281.82%-42K

-1,383.33%-77K

-165.00%-26K

End cash Position

34.31%27.41M

-51.44%23.4M

-17.64%27.21M

38.12%23.63M

90.37%20.41M

285.72%48.18M

95.62%33.04M

-56.11%17.11M

Free cash flow

154.78%4.02M

-179.30%-3.78M

210.60%3.59M

90.37%-2.47M

218.45%3.35M

20.81%-7.34M

163.72%4.77M

46.42%-3.25M

-118.22%-25.63M

48.98%-2.82M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	159.60%4.11M	-172.59%-3.61M	239.69%4.19M	94.73%-1.32M	237.69%3.6M	25.16%-6.89M	167.60%4.97M	48.57%-3M	-143.07%-25M	48.67%-2.61M
Net income from continuing operations	274.73%3.24M	-111.39%-2.2M	-46.76%-4.6M	155.68%8.31M	-61.60%-6.04M	48.08%-1.85M	462.56%19.34M	-36.96%-3.13M	45.88%-14.93M	43.90%-3.74M
Operating gains losses	102.78%3K	109.09%1K	-75.00%5K	92.96%-38K	139.35%61K	-325.00%-108K	97.88%-11K	-76.47%20K	-166.42%-540K	-2,037.50%-155K
Depreciation and amortization	7.87%329K	8.87%319K	15.00%322K	9.67%1.19M	13.82%313K	11.72%305K	9.33%293K	3.70%280K	-2.86%1.09M	6.18%275K
Deferred tax	1,065.79%443K	97.80%-69K	---138K	---3.09M	--0	--38K	---3.13M	--0	--0	--0
Other non cash items	483.95%1.15M	-21.74%-504K	-4,181.82%-471K	12.92%-600K	-27.06%124K	-464.15%-299K	39.39%-414K	91.06%-11K	-122.30%-689K	-57.82%170K
Change In working capital	72.42%-1.67M	81.36%-2.15M	1,251.57%8.08M	12.28%-10.54M	2,491.33%7.77M	4.08%-6.07M	-738.20%-11.54M	84.78%-702K	-221.35%-12.02M	-39.02%300K
-Change in receivables	294.50%8.38M	-90.44%-7.05M	-54.33%1.75M	64.15%-428K	-16.41%3.76M	25.33%-4.31M	-254.98%-3.7M	265.21%3.82M	-15.70%-1.19M	47.81%4.5M
-Change in inventory	280.70%3.52M	143.56%1.63M	5.66%-3.3M	-294.87%-2.24M	213.20%2.54M	-200.15%-1.95M	667.82%668K	-357.28%-3.5M	123.60%1.15M	30.46%-2.24M
-Change in payables and accrued expense	-590.96%-869K	-50.97%1.61M	-500.57%-1.41M	210.22%5.3M	503.01%1.48M	-58.45%177K	185.39%3.29M	134.92%353K	-301.43%-4.8M	-127.83%-366K
-Change in other current assets	-177.78%-7K	200.00%6K	55.56%14K	360.00%13K	-96.00%1K	133.33%9K	---6K	--9K	-102.07%-5K	-65.75%25K
-Change in other current liabilities	----	----	----	--0	----	----	----	----	--0	----
-Change in other working capital	----	114.05%1.66M	895.32%11.04M	-84.00%-13.18M	--0	--0	-589,600.00%-11.79M	47.54%-1.39M	-154.13%-7.16M	-125.87%-1.62M
Cash from discontinued investing activities
Operating cash flow	159.60%4.11M	-172.59%-3.61M	239.69%4.19M	94.73%-1.32M	237.69%3.6M	25.16%-6.89M	167.60%4.97M	48.57%-3M	-143.07%-25M	48.67%-2.61M
Investing cash flow
Cash flow from continuing investing activities	197.36%20.33M	18.92%-180K	-112.81%-606K	-231.90%-16.71M	-106.90%-342K	-453.16%-20.88M	-162.18%-222K	129.11%4.73M	-126.61%-5.04M	-86.77%4.95M
Net PPE purchase and sale	81.21%-84K	15.69%-172K	-141.13%-598K	-82.96%-1.15M	-17.37%-250K	-670.69%-447K	-59.38%-204K	-8.30%-248K	55.33%-628K	52.46%-213K
Net investment purchase and sale	----	----	----	-208.40%-15.42M	--0	-440.33%-20.42M	--0	131.25%5M	-125.00%-5M	-86.78%5M
Net other investing changes	25.00%-9K	55.56%-8K	60.00%-8K	-123.95%-142K	-155.42%-92K	60.00%-12K	-103.71%-18K	28.57%-20K	81.35%593K	238.78%166K
Cash from discontinued investing activities
Investing cash flow	197.36%20.33M	18.92%-180K	-112.81%-606K	-231.90%-16.71M	-106.90%-342K	-453.16%-20.88M	-162.18%-222K	129.11%4.73M	-126.61%-5.04M	-86.77%4.95M
Financing cash flow
Cash flow from continuing financing activities	-20.42M	0	0	199.42%24.67M	0	0	10.43M	14.23M	-31.79%8.24M	200.72%4.08M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--0	----
Net common stock issuance	--0	--0	--0	190.85%23.95M	--0	--0	--9.72M	--14.23M	-82.17%8.24M	--4.08M
Proceeds from stock option exercised by employees	--0	----	----	35,500.00%712K	--0	--0	----	----	--2K	--0
Cash from discontinued financing activities
Financing cash flow	---20.42M	--0	--0	199.42%24.67M	--0	--0	294.74%10.43M	--14.23M	-31.79%8.24M	200.72%4.08M
Net cash flow
Beginning cash position	-51.44%23.4M	-17.64%27.21M	38.12%23.63M	-56.11%17.11M	90.37%20.41M	285.72%48.18M	95.62%33.04M	-56.11%17.11M	113.44%38.99M	0.73%10.72M
Current changes in cash	114.45%4.01M	-124.96%-3.79M	-77.57%3.58M	130.45%6.64M	-49.31%3.25M	-1,466.99%-27.77M	448.58%15.18M	172.29%15.97M	-205.23%-21.8M	-77.33%6.42M
Effect of exchange rate changes	77.78%-2K	44.44%-20K	83.33%-7K	-48.05%-114K	-3.85%-27K	---9K	10.00%-36K	-281.82%-42K	-1,383.33%-77K	-165.00%-26K
End cash Position	34.31%27.41M	-51.44%23.4M	-17.64%27.21M	38.12%23.63M	38.12%23.63M	90.37%20.41M	285.72%48.18M	95.62%33.04M	-56.11%17.11M	-56.11%17.11M
Free cash flow	154.78%4.02M	-179.30%-3.78M	210.60%3.59M	90.37%-2.47M	218.45%3.35M	20.81%-7.34M	163.72%4.77M	46.42%-3.25M	-118.22%-25.63M	48.98%-2.82M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data